Revna Biosciences (www.RevnaBio.com) has actually sculpted a specific niche for itself in Ghana and West Africa by being the very first center in the area to protect twin ISO certifications: ISO 15189:2022 for medical diagnostics and ISO 20387:2018 for biobanking. This landmark is a testimony to RevnaBio’s steady dedication to promoting accuracy medication by driving molecular diagnostics and healing exploration in the area.
A Promise to High Quality and Person Care
The American Organization for Lab Certification (A2LA) has actually presented the ISO 15189:2022 certification upon Revna Biosciences, recognizing its devotion to providing top-tier medical screening solutions. The certification procedure involved a strenuous on-site assessment by A2LA’s assessors, confirming the center’s conformity with rigorous requirements of accuracy, dependability, and individual privacy.
Revna Biosciences’ certification includes a substantial range of human example examinations, consisting of those entailing pee, swabs, blood, bone marrow, cells examples, and plasma. With a field of expertise in bacteriology, virology, and molecular pathology, the center is committed to supplying individuals with precise and trustworthy medical diagnoses.
Biobanking Excellence
Revna Biosciences has actually additionally gained certification for its biobanking methods under ISO 20387:2018. This certification covers the whole biospecimen lifecycle, from collection and procurement to conservation, screening, storage space, and circulation of numerous cells and blood items. The business’s adherence to worldwide requirements ensures the high quality and honesty of biospecimen, therefore adding to innovations in international clinical research study.
Dr. Derrick Edem Akpalu, Chief Executive Officer and Founder of Revna Biosciences, specified, “Our twin ISO certifications mirror our dedication to quality and high quality, from example collection to information evaluation. This not just comforts individuals yet additionally advantages scientists and market companions. These certifications boost our medical research study solutions, leading the way for international therapies and diagnostics advancement. By sticking to these ISO requirements, we make certain the dependability of our archived biosamples and information, therefore improving clinicogenomic understandings and driving the innovation of individualized medication in the area. “
Dr. Yaw Asare-Aboagye, a board participant of the business, included, “We intend to satisfy the highest possible worldwide requirements as we are committed to improving accessibility to high-grade medical care and research study centers, specifically in Africa where the need for such solutions is critical.”
Global Acknowledgment and Market Alignment
A2LA, the certifying company, is renowned for its Centers for Medicare and Medicaid Solutions (CMS) Deemed Standing and International Lab Certification Teamwork (ILAC) Acknowledgment, an indicator of its online reputation as a certifying board in international medical diagnostics. Moreover, RevnaBio belongs to ISBER, a worldwide online forum for biobanking that supporters for premium requirements and advancement in biorepository administration. Revna Biosciences’ success straightens with international acknowledgment and market requirements, placing the business at the lead of clinical advancement.
Dispersed by APO Team in behalf of Revna Biosciences.
Concerning Revna Biosciences:
With a functional base in Accra, Ghana, and offering throughout West Africa, Revna Biosciences (RevnaBio) is a biomedical business devoted to progressing molecular diagnostics and healing exploration. With an objective to promote accuracy medication for all, RevnaBio is committed to unwinding the organic bases of conditions impacting Africans, individuals of African descent, and the international populace.
RevnaBio uses a detailed collection of solutions, consisting of innovative molecular diagnostics, biobanking, biomarker expedition, medical research study, main laboratory solutions, illness tracking, therapy option, and test administration. With calculated partnerships with worldwide biotech leaders such as QIAGEN, Diatech Pharmacogenetics, and Idil Biotech, RevnaBio supplies innovative biomedical solutions in the heart of West Africa.
RevnaBio holds all essential neighborhood authorizations and licenses, consisting of the Health and wellness Facilities Regulatory Authority (HeFRA) allow for tertiary labs. RevnaBio has the authorization of Ghana’s Food&& Drugs Authority (FDA), is twin ISO certified (ISO 15189:2022; ISO 20387:2018) by the American Organization for Lab Certification (A2LA) and a participant of the International Culture of Biological and Environmental Repositories (ISBER).
To find out more concerning Revna Biosciences and its cutting-edge operate in accuracy medication, please call +233-59-900-9977 or see www.RevnaBio.com.
